Regulation (EU) 2023/607 of 15 March 2023 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices
Regulation (EU) 2023/607of the European Parliament and of the Council of 15 March 2023 introduces a staggered extension of the transition period provided for in Regulation (EU) 2017/745 on medical devices (MDR), subject to certain conditions. It also deletes in both MDR and IVDR the “sell-off” deadline after which devices placed on the market before or during the transition periods that are still in the supply chain would have had to be withdrawn.
Read the news published by the European Commission on 20 March 2023.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (9 mai 2023). Regulation (EU) 2023/607 of 15 March 2023 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices. ELSIBI. Consulté le 25 avril 2025 à l’adresse https://doi.org/10.58079/o6af